Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05749159
Other study ID # 2023-0115
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 1, 2023
Est. completion date December 31, 2023

Study information

Verified date February 2023
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact Shen Jian
Phone +86 13634134320
Email sjcardiology@163.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Hiccup is a common symptom, and it is currently believed that hiccups result from diaphragmatic spasm, with onset ranging from minutes to days. Some patients may terminate on their own, or by ways such as gasping. For some patients with duration longer than 1 day, even longer than 2 days, medications may be needed, mainly: metoclopramide, eperisone hydrochloride tablets, etc. Acupuncture is also effective for some patients. Surgical treatment may be required for some clinically intractable hiccups. However, for the above interventions or treatment means, the current efficacy still needs to be improved. In the previous clinical experience, we create a new physical clinic protocol which could terminate the hiccup symptom onset instantaneously without adding extra cost to the patient, and the physiotherapy method was convenient and effective. To further validate the superiority, safety of this novel physical therapy regimen, we designed a randomised controlled, prospective, single centre clinical study aimed at comparing the efficacy and safety of the novel physical therapy with conventional pharmacotherapy in patients with hiccups.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date December 31, 2023
Est. primary completion date December 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age = 18 years - Able to swallow water Exclusion Criteria: - Allergy or contraindication to the following drugs: metoclopramide et al - Severe choking on water and difficulty swallowing were present - Impaired consciousness and inability to cooperate

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
physiotherapy
New physical therapy: a disposable cup (soft cup) to take 1/3 cup of room temperature water and place it on a table. The patient takes a sitting or standing position. The middle finger of both hands press tightly against the nose to seal the nasal cavity. At the same time, press the ear screen with both hands to close the ear canal. After that, bite the cup with teeth (hands do not touch the cup), and drink up 1-2 mouthfuls of water.

Locations

Country Name City State
China 2nd Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou Zhejiang

Sponsors (1)

Lead Sponsor Collaborator
Second Affiliated Hospital, School of Medicine, Zhejiang University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary the rate of termination of hiccup in 30 seconds the rate of termination of hiccup in 30 seconds 1 year
Primary the time course from the start of therapy to the end of hicuup the time course from the start of therapy to the end of hicuup 1 year
See also
  Status Clinical Trial Phase
Withdrawn NCT01277731 - Methylprednisolone Replacement for Dexamethasone-induced Hiccup N/A
Completed NCT05313685 - Educational Materials for Hiccups
Not yet recruiting NCT03778281 - Treatment of Chemotherapy-related Hiccups With Baclofen Phase 4